Abdoulaye Sene

Executive Director, Translational Medicine at Kartos Therapeutics - Redwood City, CA, US

Abdoulaye Sene's Colleagues at Kartos Therapeutics
Ken Christensen

Senior Director, Contracts Management and Outsourcing

Contact Ken Christensen

Mitra Shokri

Sr. Clinical Research Associate

Contact Mitra Shokri

Rob Friedman

Clinical Science Consultant

Contact Rob Friedman

Tiffanie Chan

Director, Clinical Science

Contact Tiffanie Chan

Jasmine Dayrit

Administrative Support Temp

Contact Jasmine Dayrit

View All Abdoulaye Sene's Colleagues
Abdoulaye Sene's Contact Details
HQ
N/A
Location
South San Francisco,California,United States
Company
Kartos Therapeutics
Abdoulaye Sene's Company Details
Kartos Therapeutics logo, Kartos Therapeutics contact details

Kartos Therapeutics

Redwood City, CA, US • 100 - 249 Employees
BioTech/Drugs

Kartos Therapeutics is a privately held, clinical-stage biopharmaceutical company developing a potentially best-in-class MDM2 inhibitor. Launched in 2018 by proven industry veterans, we are a passionate team based in Redwood City, California, and Bellevue, Washington. We have brought together scientists and clinicians with a deep understanding of hematology and oncology and an experienced leadership team. Together, we're building an exciting biotechnology company with a culture defined by caring, ambition, dedication, and teamwork!

N/A
Details about Kartos Therapeutics
Frequently Asked Questions about Abdoulaye Sene
Abdoulaye Sene currently works for Kartos Therapeutics, Inc..
Abdoulaye Sene's role at Kartos Therapeutics, Inc. is Executive Director, Translational Medicine.
Abdoulaye Sene's email address is ***@kartosthera.com. To view Abdoulaye Sene's full email address, please signup to ConnectPlex.
Abdoulaye Sene works in the Research industry.
Abdoulaye Sene's colleagues at Kartos Therapeutics are Ken Christensen, Michael Gulrajani, Mitra Shokri, Rob Friedman, Tiffanie Chan, Jasmine Dayrit, Jillian Duncan and others.
Abdoulaye Sene's phone number is N/A
See more information about Abdoulaye Sene